Sg Americas Securities, LLC Eagle Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$25.06 - $34.09 $199,753 - $271,731	7,971 New	7,971 $226,000
Q3 2022 Oct 31, 2022	SELL	$26.42 - $47.12 $1,822 - $3,251	-69 Reduced 0.75%	9,133 $241,000
Q2 2022 Jul 29, 2022	SELL	$41.26 - $51.35 $639,364 - $795,719	-15,496 Reduced 62.74%	9,202 $409,000
Q1 2022 Apr 29, 2022	BUY	$44.58 - $52.6 $174,084 - $205,403	3,905 Added 18.78%	24,698 $1.22 Million
Q4 2021 Feb 07, 2022	SELL	$45.82 - $56.9 $1.47 Million - $1.83 Million	-32,095 Reduced 60.68%	20,793 $1.06 Million
Q3 2021 Nov 01, 2021	BUY	$43.79 - $55.78 $250,610 - $319,228	5,723 Added 12.13%	52,888 $2.95 Million
Q2 2021 Aug 12, 2021	SELL	$36.86 - $44.5 $328,275 - $396,317	-8,906 Reduced 15.88%	47,165 $2.02 Million
Q1 2021 May 13, 2021	SELL	$40.32 - $50.97 $162,570 - $205,511	-4,032 Reduced 6.71%	56,071 $2.34 Million
Q4 2020 Feb 04, 2021	BUY	$41.72 - $51.34 $1.55 Million - $1.91 Million	37,162 Added 161.99%	60,103 $2.8 Million
Q3 2020 Nov 09, 2020	SELL	$37.02 - $51.28 $1.24 Million - $1.72 Million	-33,488 Reduced 59.35%	22,941 $975,000
Q2 2020 Jul 20, 2020	BUY	$43.24 - $55.02 $873,145 - $1.11 Million	20,193 Added 55.73%	56,429 $2.71 Million
Q1 2020 Apr 30, 2020	BUY	$34.37 - $60.07 $517,165 - $903,873	15,047 Added 71.01%	36,236 $1.67 Million
Q4 2019 Jan 28, 2020	BUY	$54.32 - $64.31 $686,550 - $812,814	12,639 Added 147.82%	21,189 $1.27 Million
Q3 2019 Nov 04, 2019	BUY	$53.25 - $59.98 $455,287 - $512,829	8,550 New	8,550 $484,000
Q2 2019 Jul 29, 2019	SELL	$46.61 - $58.45 $116,851 - $146,534	-2,507 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$38.66 - $51.82 $204,434 - $274,024	-5,288 Reduced 67.84%	2,507 $127,000
Q4 2018 Feb 01, 2019	BUY	$36.72 - $67.73 $286,232 - $527,955	7,795 New	7,795 $314,000
Q3 2018 Nov 06, 2018	SELL	$66.65 - $83.86 $469,615 - $590,877	-7,046 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$51.25 - $76.62 $204,436 - $305,637	-3,989 Reduced 36.15%	7,046 $533,000
Q1 2018 May 03, 2018	BUY	$52.16 - $66.86 $190,384 - $244,039	3,650 Added 49.42%	11,035 $581,000
Q4 2017 Jan 24, 2018	BUY	$49.6 - $60.87 $142,550 - $174,940	2,874 Added 63.71%	7,385 $395,000
Q3 2017 Nov 07, 2017	BUY	$46.62 - $60.36 $210,302 - $272,283	4,511	4,511 $269,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account